SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006088
Filing Date
2021-05-06
Accepted
2021-05-06 08:34:59
Documents
100
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210331x10q.htm   iXBRL 10-Q 1959248
2 EX-10.1 tmb-20210331xex10d1.htm EX-10.1 385452
3 EX-31.1 tmb-20210331xex31d1.htm EX-31.1 10557
4 EX-31.2 tmb-20210331xex31d2.htm EX-31.2 10611
5 EX-32.1 tmb-20210331xex32d1.htm EX-32.1 7945
  Complete submission text file 0001558370-21-006088.txt   9803830

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210331.xsd EX-101.SCH 94173
7 EX-101.CAL tmb-20210331_cal.xml EX-101.CAL 59068
8 EX-101.DEF tmb-20210331_def.xml EX-101.DEF 429718
9 EX-101.LAB tmb-20210331_lab.xml EX-101.LAB 595051
10 EX-101.PRE tmb-20210331_pre.xml EX-101.PRE 644937
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210331x10q_htm.xml XML 1429700
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 21895949
SIC: 2834 Pharmaceutical Preparations